Clinical Trial Update: The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Biodentine for class V dental lesions and its impact on oral health-related quality of life was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Abrasion
• Oral Health-related Quality of Life

Drugs mentioned

• Biodentine (tricalcium silicate cement)

Snippet

Sponsor: University of Michigan | Conditions: Quality of Life, Cervical Abrasion | Phase 3 | Status: TERMINATED | Results posted: 2021-07-19